Abstract
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Patients with hepatocellular carcinoma are at high risk of developing HCC. Risk factors for developing HCC include dietary aflatoxin (AFB1) ingestion, chronic alcoholism, chronic hepatitis virus (HBV, HCV) infections and hereditary conditions such as hereditary hemochromatosis. Hepatic carcinogenesis is a complex process and is associated with genetic and epigenetic changes, and different genes have been implicated in the pathogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Rocken C, Carl-McGrath S. Pathology and pathogenesis of hepatocellular carcinoma. Dig Dis. 2001;19(4):269–78.
Dominguez-Malagon H, Gaytan-Graham. Hepatocellular carcinoma: an update. Ultrastruct Pathol 2001;25(6):497–516.
Mendizabal M, Reddy KR. Current management of hepatocellular carcinoma. Med Clin North Am 2009;93(4):885–900.
Forner A, Hessheimer AJ, Real MI, Bruix J. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hamatol 2006;60(2):89–98.
Chappel G, Kutanzi K, Uehara T, Tryndyak V, Hong HH, Hoenerhoff M, et al. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int J Cancer. 2014;134(12):2778–88.
El-Serag HB. Hepatocellular carcinoma: an epidemiology view. J Clin Gastroenterol 2002;35(5):(suppl 2) S72–8.
Kudo M. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol. 290;25(3):439–52.
Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment The Oncologist 2010;10(suppl 4):14–22.
Xue KX. Molecular genetic and epigenetic mechanisms of hepatogenesis. Ai Zhng. 2005;24(6):757–68.
Tabor E. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function. Princess Takamatsu Symp. 1995;25:151–61.
Nita ME, Alves AF, Carrilho FJ, Ono-Nita SK, de Mello ES, Gama-Rodrigues JJ. Molecular aspects of hepatic carcinogenesis. Rev Inst Med Trop S, Paulo. 2002; 44(1): https://doi.org/10.1590/S0036-4665200200010007.
Cho YK, Kim JK, Kim WJ, Chug JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology. 2010;51(4):1284–90.
Asahina Y, Tsuchiya K, Tamahi N, Hirayama I, Tanaka T, Sato M, et al. Effect of aging on risk of hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 2010;52:518–527.
Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42:S206–14.
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and Molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576.
Fung J, Lai CL, Yuen MF. Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect. 2009;15(11):964–70.
Honda T, Miyaaki H, Ichikawa T, Taura N, Miuma S, Shibata H, et al. Clinical characteristics of hepatocellular carcinoma in elderly patients. Oncol Lett 2011;2(5):851–854.
Yeh CN, Lee WC, Jeg LB, Chen MF. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology. 2004;51(55):219–23.
Reddy SK, Barbas AS, Turley RS, Gamblin TC, Gellen DA, Marsh JW, et al. Major liver resection in elderly patients: a multi-institutional analysis. J Am Coll Surg. 2011;21(5):787–95.
Takenaka K, Shimada M, Higashi H, et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg. 1994;129(8):846–50.
Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early stage hepatocellular carcinoma in patients with cirrhosis. Alim Pharmacol Ther. 2009;30:37–41.
Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, DiBisceglie AM, HALT – C Trial Group. et al. Des-gamma-carboxy prothrombin and alpha – fetoprotein biomarkers for early detection of hepatocellular carcinoma. Gastroenterology. 2010;138:493–50.
Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatalogy. 2011;53(3):1020–1022.
Bertino G, Neri S, Bruno CM, Ardne AM, Calvagno GS, Malaguanera M, et al. Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Minerva Med. 201;102(5):363–71.
Forner A, Reig ME, deLope CS, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61–74.
Ng KK, Poon RT. Current treatment strategy for hepatocellular carcinoma. Saudi Med J. 2007;8(9):1330–8.
Choi JY. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea. Oncology. 2011;81 Suppl 1:141–146.
Borzio M, Dionigi E, Parisi G, Raguzzi I, Sacco R. Management of hepatocellular carcinoma I the elderly. World J Hepatol. 2015;7(11):1521–9.
Pugh RN, Murray-Lyon IM, Dawson JL, Pietrovic MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 173;60:646–9.
Sloss A, Kubler P. Prescribing in liver disease. Aust Prescr. 2009;32:32–5.
Cabibbo G, Maida m, Camma C, Craxi A. Is efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age? Expert Rev Anticancer Ther. 2013;13(12):1355–61.
Brunot A, Le Sourd S, Prachi M, Edelme J. Hepatocellular carcinoma in elderly patients; challenges and solutions. J Hepatocell Carcinoma. 2016;3:9–18.
Clegg A, Youg J, Iilffe S, Rikert MO, Rockwood K. Frailty in older people. Lancet 2013;381(9868):752–762.
Zhang W, Sun B. Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients on the SEER data base. Oncotarget 2015;(2):633–641.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2018). Hepatocellular Carcinoma. In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-33434-9_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-33434-9_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33433-2
Online ISBN: 978-3-319-33434-9
eBook Packages: MedicineReference Module Medicine